Sit Investment Associates Inc. increased its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,724,706 shares of the company’s stock after buying an additional 125,599 shares during the period. Sit Investment Associates Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $24,836,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the stock. Jane Street Group LLC purchased a new position in BlackRock Health Sciences Term Trust in the third quarter valued at approximately $357,000. Raymond James Financial Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at $10,869,000. Commonwealth Equity Services LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 3.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock worth $1,475,000 after acquiring an additional 3,635 shares during the period. Corient Private Wealth LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 24.9% during the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock worth $378,000 after acquiring an additional 5,224 shares during the period. Finally, Wolverine Asset Management LLC raised its stake in BlackRock Health Sciences Term Trust by 496.1% in the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock valued at $2,702,000 after acquiring an additional 156,141 shares during the period.
BlackRock Health Sciences Term Trust Stock Down 5.0 %
NYSE BMEZ opened at $13.60 on Friday. BlackRock Health Sciences Term Trust has a 52 week low of $13.52 and a 52 week high of $16.75. The firm’s 50-day simple moving average is $15.59 and its two-hundred day simple moving average is $15.54.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Financial Services Stocks Investing
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.